Extendicare (EXE) Stock Price, News & Analysis

Company Overview

Extendicare is a leading provider of care and services for seniors across Canada, operating under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. We are committed to delivering quality care to meet the needs of the growing seniors' population, inspired by our mission to provide people with the care they need, wherever they call home. We deliver more than 27 million hours of home health care services annually, operate a network of 97 long-term care homes (58 owned, 39 under management contracts), and provide group purchasing services to third parties representing approximately 161,700 beds across Canada. Extendicare proudly employs approximately 32,500 individuals and manages an additional 6,000 joint venture employees, all of whom are highly qualified, trained and dedicated team members and passionate about providing high-quality care and services to help people live better.

Key Stats

• Today's Range: C$26.17 to C$27.43
• 50-Day Range: C$26.66 to C$35.48
• 52-Week Range: C$14.46 to C$39.14
• Volume: 896,493 shs
• Average Volume: 437,215 shs
• Market Capitalization: C$2.53 billion
• P/E Ratio: 20.41
• Dividend Yield: 1.92%
• Price Target: C$37.00
• Consensus Rating: Buy

Extendicare Stock Analysis - MarketRank™

Extendicare scored higher than 72% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.1 / 5
• Analyst Rating: Buy

Consensus Rating

Extendicare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 7 buy ratings, no hold ratings, and no sell ratings.

Upside Potential

Extendicare has a consensus price target of C$37.00, representing about 38.8% upside from its current price of C$26.66.

Amount of Analyst Coverage

Extendicare has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Extendicare is 20.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.05.

Price to Earnings Ratio vs. Sector

The P/E ratio of Extendicare is 20.41, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.02.

Price to Book Value per Share Ratio

Extendicare has a P/B Ratio of 6.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for EXE.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Extendicare pays a meaningful dividend of 1.90%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Extendicare does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Extendicare is 39.23%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.39

News Sentiment

Extendicare has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Extendicare this week, compared to 1 article on an average week.

Search Interest

Only 18 people have searched for EXE on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.

Company Ownership

• Score: 0.9 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Extendicare insiders have not sold or bought any company stock.

Percentage Held by Insiders

13.92% of the stock of Extendicare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

30.20% of the stock of Extendicare is held by institutions.

Company Calendar

• Ex-Dividend for 8/17 Dividend: 7/31/2026
• Last Earnings: 8/06/2026
• Record date for 8/17 Dividend: 8/17/2026
• Dividend Payable: 8/17/2026
• Today: 10/10/2026

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: TSE:EXE
• CIK: N/A
• Web: www.extendicare.com
• Phone: 905-470-4000
• Fax: N/A
• Employees: 23,500
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Extendicare: C$37.00
• High Price Target: C$44.00
• Low Price Target: C$30.00
• Potential Upside/Downside: +38.8%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): C$1.31
• Trailing P/E Ratio: 20.41
• Forward P/E Ratio: 43.46
• P/E Growth: N/A
• Net Income: C$65.46 million
• Net Margins: 6.13%
• Pretax Margin: N/A
• Return on Equity: 36.33%
• Return on Assets: 7.16%

Debt

• Debt-to-Equity Ratio: 159.54
• Current Ratio: 0.75
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: C$1.98 billion
• Price / Sales: 1.28
• Cash Flow: C$8.33 per share
• Price / Cash Flow: 3.20
• Book Value: C$4.24 per share
• Price / Book: 6.29

Miscellaneous

• Outstanding Shares: 95,046,000
• Free Float: N/A
• Market Cap: C$2.53 billion
• Optionable: Not Optionable
• Beta: 1.39